INM
InMed Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$1.75
+4.17%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- 0.91x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 109.19x
Liquidity & coverage
- Current ratio
- 504.31x
- Quick ratio
- 504.31x
- Cash ratio
- 452.97x
- Interest coverage
- —
- EBITDA / interest
- -936.82x
- Working capital
- $1.3B
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026